88 related articles for article (PubMed ID: 2123569)
1. Transfusion-related human immunodeficiency virus in patients with haemophilia in Johannesburg.
Cohn RJ; MacPhail AP; Hartman E; Schwyzer R; Sher R
S Afr Med J; 1990 Dec; 78(11):653-6. PubMed ID: 2123569
[TBL] [Abstract][Full Text] [Related]
2. Clinical and serological study of the human immunodeficiency virus infection in a cohort of multitransfused persons.
Mokhbat JE; Naman RE; Rahme FS; Farah AE; Zahar KL; Maalouf A
J Med Liban; 1989; 38(1):9-14. PubMed ID: 2519339
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of HIV-antibodies in patients with haemophilia in Hungary.
Ujhelyi E; Králl G; Füst G; Medgyesi GA; Hollán SR; Zimonyi I; Berkessy S; Nagy K; Földes I; Mayer V
Haematologia (Budap); 1988; 21(2):83-9. PubMed ID: 3262077
[TBL] [Abstract][Full Text] [Related]
4. HIV transmission to patients with hemophilia by heat-treated, donor-screened factor concentrate.
Remis RS; O'Shaughnessy MV; Tsoukas C; Growe GH; Schechter MT; Palmer RW; Lawrence DN
CMAJ; 1990 Jun; 142(11):1247-54. PubMed ID: 2111726
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus (HIV) antibodies in patients with haemophilia and other inheritable blood clotting disorders in south west Poland (Lower Silesia region).
Czerchawski L; Lindhardt BO; Ulrich K; Szymaniec S; Pejcz J; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1988; 36(1):61-9. PubMed ID: 3148300
[TBL] [Abstract][Full Text] [Related]
6. AIDS and haemophilia.
Bloom AL
Biomed Pharmacother; 1985; 39(7):355-65. PubMed ID: 3938297
[TBL] [Abstract][Full Text] [Related]
7. AIDS and haemophilia.
Carr R
Biomed Pharmacother; 1985; 39(7):347-50. PubMed ID: 3006817
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of IgG antibodies to human parvovirus B19 in haemophilia children treated with recombinant factor (F)VIII only or with at least one plasma-derived FVIII or FIX concentrate: results from the French haemophilia cohort.
Gaboulaud V; Parquet A; Tahiri C; Claeyssens S; Potard V; Faradji A; Peynet J; Costagliola D;
Br J Haematol; 2002 Feb; 116(2):383-9. PubMed ID: 11841442
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and transmission of human immunodeficiency virus in Japan.
Kurimura T; Kawatani T; Hattori N; Tsuchie H
AIDS Res; 1986 Dec; 2 Suppl 1():S163-6. PubMed ID: 3103639
[TBL] [Abstract][Full Text] [Related]
10. Immunological studies in haemophilic children.
Nicholson NA; Karabus CD; Beatty DW; Becker WB
S Afr Med J; 1987 May; 71(9):567-9. PubMed ID: 2953077
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis, type B in haemophiliacs. Relation to the source of clotting factor concentrates.
Holsteen V; Skinhoj P; Cohn J
Scand J Haematol; 1977 Mar; 18(3):214-8. PubMed ID: 847395
[TBL] [Abstract][Full Text] [Related]
12. [Clinical analysis of 4 Chinese hemophiliacs with human immunodeficiency virus infection].
Tang DJ; Xu YH; Dai D
Zhonghua Nei Ke Za Zhi; 1989 Aug; 28(8):466-8, 509. PubMed ID: 2513171
[TBL] [Abstract][Full Text] [Related]
13. Activated prothrombin concentrate for patients with factor VIII inhibitors.
Kurczynski EM; Penner JA
N Engl J Med; 1974 Jul; 291(4):164-7. PubMed ID: 4834485
[No Abstract] [Full Text] [Related]
14. Absence of anti-human immunodeficiency virus types 1 and 2 seroconversion after the treatment of hemophilia A or von Willebrand's disease with pasteurized factor VIII concentrate.
Schimpf K; Brackmann HH; Kreuz W; Kraus B; Haschke F; Schramm W; Moesseler J; Auerswald G; Sutor AH; Koehler K
N Engl J Med; 1989 Oct; 321(17):1148-52. PubMed ID: 2507917
[TBL] [Abstract][Full Text] [Related]
15. [Home treatment in hemophilia].
Pabinger I; Niessner H; Korninger C; Nowotny C; Stain M; Kyrle PA; Lechner K
Wien Klin Wochenschr; 1987 Nov; 99(22):773-7. PubMed ID: 3124354
[TBL] [Abstract][Full Text] [Related]
16. HIV seroconversion in Thai hemophiliacs up to 1991.
Isarangkura P; Chuansumrit A; Hathirat P; Panthangkura W; Mahaphan W; Limsuwan A; Chiewsilp P
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():191-4. PubMed ID: 7886571
[TBL] [Abstract][Full Text] [Related]
17. Clinical and biological survey of haemophilia A and B patients infused with French heat-treated concentrates.
Parquet A; Boneu B; Bosser C; Cazenave JP; Dirat G; Gazengel G; Grunebaum L; Sultan Y; Verroust F; Wiesel ML
Nouv Rev Fr Hematol (1978); 1988; 30(4):205-7. PubMed ID: 3143099
[TBL] [Abstract][Full Text] [Related]
18. Haemophilia--darkest hours before the dawn.
Street AM; Ekert H
Med J Aust; 1996 Apr; 164(8):453-5. PubMed ID: 8614331
[No Abstract] [Full Text] [Related]
19. [Prevalence of inhibitors in hemophiliacs with reference to the transfusion of blood products (author's transl)].
Kamiya T
Rinsho Byori; 1978; 26(4):291-7. PubMed ID: 671775
[No Abstract] [Full Text] [Related]
20. Haemophilia care in Zimbabwe.
Adewuyi JO; Coutts AM; Levy L; Lloyd SE
Cent Afr J Med; 1996 May; 42(5):153-6. PubMed ID: 8771937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
